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Background: Cryoplasty combines mechanical dilatation with the delivery of hypothermia to atherosclerotic plaques. The
response of vascular smooth muscle cells (SMCs) and endothelial cells (ECs) to supercooling and subsequent rewarming
is still not clear. This study investigated the differential effects of vascular cell survival and proliferation in an in vitro
model simulating cryoplasty.
Methods: Bovine aortic ECs and SMCs were cultured separately with medium supplemented with 10% fetal bovine serum.
The samples were supercooled to –10°C for 0, 60, or 120 seconds on a cooling stage and then rewarmed in an incubator
at 37°C for 0, 6, 12, or 24 hours. Terminal deoxynucleotide transferase-mediated deoxy uridine triphosphate nick-end
labeling (TUNEL) and 5=-bromo-2=-deoxyuridine incorporation were used to measure the degree of apoptosis and
proliferation respectively. Activation of protein kinase B (AKT), P70 S6 kinase, and P44/42 mitogen-activated protein
kinase (MAPK) were assessed by Western blot and quantified using densitometry. Results are given as mean  standard
error of mean and analyzed by analysis of variance.
Results: SMC and EC apoptosis were significantly increased with increasing supercooling and rewarming time, with a
higher rate in SMCs. SMC apoptosis was maximal at 60 seconds cooling, followed by 24 hours rewarming (17.05% 
0.44%), whereas maximal EC apoptosis was after 120 seconds cooling, followed by 24 hours rewarming (4.21% 0.22%,
P < .05). Higher AKT activation was observed in ECs, with a maximum obtained of 3.34-fold at 120 seconds cooling
with 24 hours rewarming (P < .05); only modest activation was found in SMCs. ECs had a decreased proliferation with
cooling and rewarming time, and although SMCs maintained their low proliferative rate, ECs still had a higher overall
proliferation rate that was statistically significant at 60 and 120 seconds cooling without rewarming compared with
noncooling and nonrewarming (P < .05). Both p70S6 kinase and p44/42 MAPK activities decreased in SMCs, with
significant drop at 60 seconds cooling, followed by 12 hours rewarming (P < .05). However, ECs showed a significant
rise of P70 S6 kinase activity at 60 seconds cooling with 12 hours rewarming by 1.62-fold and P44/42 MAPK at 120
seconds cooling with 24 hours rewarming by 1.74-fold (P < .05).
Conclusion: The higher apoptosis and lower proliferation of SMCs compared with ECs demonstrate the different effects of
supercooling and rewarming on different vascular cell types. This information may be important in helping to understand the
mechanism by which cryoplasty of atherosclerotic lesions may result in less restenosis. (J Vasc Surg 2007;46:557-64.)
Clinical Relevance: Restenosis is a major limitation of percutaneous transluminal angioplasty for peripheral vascular
disease. Although the underlying mechanisms are not well understood, it is generally believed that arterial recoil and
neointimal hyperplasia in the setting of thrombus formation, matrix overproduction, and smooth muscle cell (SMC)
migration and proliferation play significant roles. Cryoplasty, which combines mechanical dilatation of the vessel wall
with the delivery of cold thermal energy, has been recently developed. We hypothesize that cryoplasty, apart from the
mechanical force, exerts a thermal effect on the vessel wall that may influence cellular proliferation and survival. In this
study, we directly compared the effects of supercooling and rewarming on bovine aortic SMC and endothelial cell (EC)
apoptosis and proliferation in a model simulating the temperature changes induced by cryoplasty. We definitively
demonstrated that the apoptotic rate of ECs is significantly less than that of SMCs under the same conditions, although
the apoptotic rate of both increased with increasing supercooling and rewarming. These results provide several potential
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doi:10.1016/j.jvs.2007.04.072Restenosis is a major limitation of percutaneous trans-
luminal angioplasty for peripheral vascular disease. It occurs
in about 40% of femoropopliteal angioplasties1 year after
the procedure.1 Although the underlying mechanisms are
not well understood, it is generally believed that arterial
recoil and neointimal hyperplasia in the setting of thrombus
formation, matrix overproduction, and smooth muscle cell
(SMC) migration and proliferation play significant roles.2
In a balloon-injury rat carotid model, Clowes et al3 ob-
served that although SMC proliferation persisted at a high
level up to 12 weeks after the injury, there was no increase
in neointimal cell number. This suggested that other mech-
anisms such as cell death might also be involved. This idea
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70% of medial SMCs in a rat carotid artery were apoptotic
30 minutes after balloon injury.
Endothelial cells (ECs) also play an important role in
the modulation of healing process after angioplasty. For
instance, some investigators have reported that decreasing
endothelium-derived contracting factors or enhancing
endothelium-derived relaxing factors were effective in pre-
venting restenosis.5 The intact confluent ECs may also
produce heparin sulfate to inhibit intimal proliferation; but
regenerating ECs may have an opposite effect.6
Cryoplasty, which combines mechanical dilatation of
the vessel wall with the delivery of cold thermal energy, has
been recently developed. Instead of using saline in the
balloon, liquid nitrous oxide, which evaporates into gas
upon entering the balloon, is used, causing the balloon to
dilate and cool to 10°C. The balloon is usually pro-
grammed to inflate to 6 to 8 atm, and the dilatation lasts for
20 to 60 seconds. Freezing extends approximately 0.5 mm
into the vessel wall.7-9 Several clinical studies have reported
favorable patency rates rate in treating femoropopliteal
arterial disease,7 but the underlying mechanism remains
unclear.9
We hypothesize that cryoplasty, in addition to the
mechanical force, exerts a thermal effect on the vessel wall
that may influence the underlying cells. We therefore
sought to compare the effects of supercooling and rewarm-
ing on bovine aortic SMCs and EC apoptosis and prolifer-
ation in a model simulating the temperature changes in-
duced by cryoplasty by using terminal deoxynucleotide
transferase-mediated deoxy uridine triphosphate nick-end
labeling (TUNEL) and 5=-bromo-2=-deoxyuridine (BrdU)
assays, respectively. To understand the underlying signaling
pathways involved, we also examined protein kinase B
(AKT), a threonine/serine kinase involved in cell survival
control, andmitogen-activated protein kinase (MAPK) and
P70S6 kinase, important cellular markers for transcription
and translation, respectively.
METHOD
Cell culture. Bovine thoracic aortic ECs and SMCs
were obtained as previously described.10,11 Cells were main-
tained in Dulbecco modified Eagle’s medium F-12 (GIBCO
BRL,Gaithersburg,Md) supplementedwith 10% fetal bovine
serum (Gemini BioProducts, Woodland, Calif), 5 g/mL
deoxycytidine/thymidine (Sigma-Aldrich, St Louis,Mo), and
antibiotics (penicillin, 100 U/mL; streptomycin sulfate, 100
mg/mL; amphotericin, 25 mg/100 mL; GIBCO-BRL) at
37°C in a humidified incubator with 5% carbon dioxide. Cells
of passage four to 11 were seeded on 6-well plates (Becton
Dickinson, Frankin Lakes, NJ) before experimentation.
Supercooling and re-warming system. A cooling ap-
paratus previously described12,13 was modified slightly. A
refrigerated circulator (VWR International, West Chester,
Pa) was connected to a cryostage custom-made to accom-
modate six-well plates (Cryovascular Systems, Inc, Los
Gatos, Calif). The design of the cryostage was optimized to
deliver the same temperature to each of the six wells of theculture plate by creating symmetric flow channels (Fig E1,
online only). Ethylene glycol was used as a coolant to bring
the temperature of the cryostage to –21°C. The tempera-
ture changes of 1 mLmedium per well on the six-well plate
placed on the cryostage were recorded (Fig E2, online
only). The temperature on the media dropped to –6.2°C
by 60 seconds and –14.7°C by 120 seconds. This temper-
ature curve is similar to the temperature curve obtained
when cryoplasty is performed using the PolarCath balloon
(Boston Scientific Co, Natick, Mass; Fig E3, online only).
Experiments were performed by placing the culture
plates for 0, 60, or 120 seconds on the cryostage, and the
plates were then rewarmed in a 37°C humidified incubator
for 0, 6, 12, or 24 hours.
TUNEL assay. To directly compare the effect of su-
percooling and rewarming on EC and SMC apoptosis, the
cells were separately seeded (20,000 cells/well) onto the
six-well culture plates and maintained in 10% medium for 3
days. ECs were seeded on three wells and SMCs were
seeded in the remaining three wells. TUNEL assays and
lysate collection for AKT activity were performed on day 3
when the cells attained 80% confluence.
Apoptosis was assessed by the TUNEL assay. In brief,
cells were fixed with 4% paraformaldehyade in phosphate-
buffered saline (PBS) and permeabilized with 0.1% Triton
X-100 containing 0.1% sodium citrate in distilled water.
Nonspecific endogenous peroxide was blocked with 3%
hydrogen peroxide in methanol. The degree of apoptosis
was detected by using an in situ cell death detection kit
(POD; Roche Diagnostics, Mannheim, Germany) accord-
ing to the manufacturer’s instructions. The labeled DNA
was visualized with 3,3=diaminobenzidine (DAB) as chromo-
gen and counterstained with hematoxylin. The percentage of
TUNEL-positive cells was counted by phase-contrast micros-
copy (Olympus, Melville, NY) at200 and150magnifica-
tions for ECs and SMCs, respectively.
Proliferation assay using 5=-bromo-2=-deoxyuridine
incorporation. To determine proliferation, ECs or SMCs
were separately seeded (15,000 cells/well) onto the six-
well plates with 10% medium on the first day. ECs were
seeded on three wells and SMCs were seeded in the remain-
ing three wells. Pilot studies indicated that seeding ECs at
15,000 cells/well was optimal to minimize contact inhibi-
tion right after seeding. Cells were synchronized in 1%
medium for another 24 hours before exposure to super-
cooling and rewarming so as to inhibit cell cycle progres-
sion, while keeping the cells viable. BrdU assays and lysate
collection for MAPK and P70S6 kinase were performed on
day 2 when the cells reached 50% confluence.
BrdU antigen (Sigma-Aldrich) was added 1 hour be-
fore the end of rewarming at a final concentration of 10
M. For the non-rewarming groups, BrdU antigen was
added 1 hour before supercooling. After each experimental
time point, cells were fixed with 4% paraformaldehyde in
PBS. Nonspecific endogenous peroxidase was blocked with
3% hydrogen peroxide, followed by 5% goat serum and
DNA denaturation with 2M hydrogen chloride before
incubation with anti-BrdU antibody at concentration of
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second antibody conjugated with horseradish peroxidase
and DAB as a substrate and counterstained with hematox-
ylin. The percentage of positively stained cells was deter-
mined by phase-contrast microscopy at magnifications of
150 for ECs and 100 for SMCs.
Immunoblot technique. After exposure to super-
cooling and rewarming, cells were washed with ice-cold
PBS and scraped in lysis buffer containing 50 mM N-2-
hydroxyethylpiperazine-N=-2-ethanesulfonate (HEPES) at
pH 7.4, 150 mM sodium chloride, 10% glycerol, 1% Triton
X100, 1.5 mM magnesium chloride (MgCl2●6H20), 1
mM ethylenediaminetetraacetic acid, 100 mM sodium flu-
oride, 10 mM sodium pyrophosphate, 1mM sodium or-
thovanadate, 10 mg/ml leupeptin, and 1mM phenylmeth-
ylsulfonyl fluoride. Cell lysates were then centrifuged to
collect supernatant. Protein quantification was calculated
by the modified Branford technique using a spectropho-
tometer (Beckman Coulter, Fullerton, Calif) and linear
regression using SigmaStat 1.0 software (Systat Software
Inc., Richmond Calif).
Equal amount of protein (30 g) from each sample was
separated with 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and transferred to a Hybond-ECL ni-
trocellular membrane (Amersham BioSciences, Bucking-
shire, UK). The membranes were incubated with either
phosphorylated AKT antibody (serine 473; Cell Signalling
Technology, Beverly, Mass) or antiphospho-P70S6 kinase
antibody (Thr 421/Ser 424), anti-P70S6 kinase antibody,
antiphospho-P44/42MAPK antibody (Tyr 202/Tyr 204)
or anti-P44/42 MAPK antibody (Cell Signaling Technol-
ogy) overnight at 4°C and were detected by using antirab-
bit antibody immunoglobulin G/horseradish peroxidase
conjugate (1:1000 dilution; Cell Signaling Technology)
and a electrochemiluminescent detection system (Amer-
sham Biosciences). Equal protein loading was assessed by
stripping the membrane and probing with total AKT anti-
body (Cell Signaling Technology). All blots were quanti-
fied with densitometer (BioImage, Ann Arbor, Mich).
Statistical analysis. Data are represented as themean
standard error of mean. Different groups were compared
using analysis of variance, with post hoc analysis using Fisher
protected least significant difference test (StatView 5.0 soft-
ware). Statistical significance was defined at P .05.
RESULTS
Endothelial cell and smooth muscle cell apoptosis
after exposure to supercooling and rewarming.
TUNEL-positive cells increased with supercooling and re-
warming in both ECs and SMCs. In ECs (Fig 1, A), the
positive cells of the control, noncooled group increased
from 1.14% 0.17% at 0 hour to 2.31% 0.62% (P .05)
by 24 hours rewarming. After exposure to 60 or 120
seconds cooling, the TUNEL positive EC increased to
2.80% 0.35% and 4.21% 0.22% (P .05), respectively,
at 24 hours rewarming.
Conversely, the rate of apoptosis was much higher in
SMCs (Fig 1, B). In the noncooling group, TUNEL-positive SMCs increased from 1.56%  0.32% at 0 hour to
6.85% 1.88% (P .05) at 24 hours rewarming. In the 60
and 120 seconds cooling group, the positive cells increased
to 17.05%  0.44% (P  .05) and 8.81%  2.47% (P 
.05), respectively, at 24 hours rewarming.
Effect of supercooling and rewarming on protein
kinase B phosphorylation. AKT activity was assessed by
measuring the phosphorylation of the Ser 473 site. AKT
phosphorylation was increased in ECs after supercooling
and rewarming (Fig 2, A). In the noncooling group, a
gradual decline in AKT phosphorylation was noted. In ECs
exposed to 60 seconds cooling, the phosphorylation of
AKT peaked after 6 hours rewarming by 2.19-fold. Further
Fig 1. Apoptosis of (A) endothelial cells (ECs) and (B) smooth
muscle cells (SMCs) after supercooling and rewarming as evaluated
by terminal deoxynucleotide transferase-mediated deoxy uridine
triphosphate nick-end labeling (TUNEL) assay. The percentage of
positive TUNEL cells is indicated on the y axis and the rewarming
time is indicated on the x axis. The clear bar represents 0-second
cooling group, the diagonal bar represents 60-second cooling
group, and the dotted bar represents 120-second cooling group.A,
Apoptosis of ECs, as indicated by the TUNEL-positive cells,
increased with supercooling and rewarming time (*P  .05 com-
pared with 0 hour rewarming and same cooling time; P  .05
compared with 6 hours rewarming and same cooling time; P 
.05 compared with 0 seconds cooling, followed by same hour
rewarming; P .05 compared with 60 seconds cooling, followed
by same hour rewarming). B, Apoptosis of SMCs as indicated by
the TUNEL-positive cells increased with supercooling and re-
warming time (*P  .05 compared with 0 hours rewarming with
same cooling time; P  .05 compared with 6 hours rewarming
with same cooling time; P  .05 compared with 12 hours
rewarming with the same cooling time; P .05 compared with 0
seconds cooling with same rewarming hours; †P  .05 compared
with 60 seconds cooling with same rewarming hours). Data are
presented with the standard error of the mean.increase of AKT phosphorylation was observed after 120
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3.34-fold (P  .05). In contrast, the level of AKT phos-
phorylation was significantly lower in SMCs (Fig 2, B).
Phosphorylation of AKT was the highest in the SMC
exposed to 60 seconds cooling and then 24 hours rewarm-
ing by 1.85-fold (P  .05).
Incorporation of 5=-bromo-2=-deoxyuridine in en-
dothelial cells and smooth muscle cells after exposure to
supercooling and rewarming. To assess the effect of
supercooling and rewarming on vascular cell proliferation,
BrdU incorporation was used. In the control, noncooled
group of ECs (Fig 3, A), the rate of positive BrdU cells
dropped from 38.13% 1.34% at baseline (no rewarming),
to 22.45%  3.65% at 6 hours rewarming (P  .05),
32.02%  4.36% at 12 hours rewarming (P  .05) and
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Fig 2. Western blots of protein kinase B (AKT) phosphorylation
after supercooling and rewarming in (A) endothelial cells (EC) and
(B) smooth muscle cells (SMC). Representative immunoblots are
of AKT phosphorylation after 0, 60, and 120 seconds supercool-
ing, followed by 0, 6, 12, and 24 hours rewarming. The upper
immunoblots represent the phosphorylation of AKT (Ser 473)
(pAkt) and the lower immunoblots represent the loading control
using anti-total Akt antibody (tAkt). Data are presented with the
standard error of the mean. A, Significant activation was noted
after 120 seconds cooling, followed by 24 hours rewarming (*P
.05 compared with 0 hours rewarming). B, Significant activation
was noted after 60 seconds cooling, followed by 24 hours rewarm-
ing (*P  .05 compared with 0 hours rewarming).10.41% 3.78% at 24 hours re-warming (P .05). In ECscooled for 60 and 120 seconds, the proliferation rate slowly
decreased to 10.57% 3.52% and 12.68% 0.46%, respec-
tively, at 24 hours rewarming.
In contrast, there was no significant difference in BrdU
labeling between different cooling groups of SMCs (Fig 3,
B). BrdU incorporation in SMCs was 7.30%  1.10% at
basal levels and remained at this low proliferative rate with
all the cooling and rewarming regimens.
Effect of supercooling and rewarming on P70 S6
kinase and P44/42 mitogen-activated protein kinase
phosphorylation. P70 S6 kinase phosphorylation gener-
ally increased with supercooling and rewarming time in
ECs (Fig 4, A), with a significant peak at 60 seconds
cooling with 12 hours rewarming by 1.62-fold compared
with 60 seconds cooling without rewarming (P  .05).
Conversely, the P70 S6 kinase phosphorylation decreased
with rewarming time in SMCs, with a significant drop by
0.44-fold at 60 seconds cooling with 12 hours rewarming
(P  .05). It was also significant at 0 seconds cooling with
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Fig 3. Proliferation of (A) vascular endothelial cells (EC) and (B)
vascular smooth muscle cells (SMC) after supercooling and re-
warming as evaluated by 5=-bromo-2=-deoxyuridine (BrdU) assay.
The percentage of BrdU labeling is indicated on the y axis and the
rewarming time is indicated on the x axis. Data are presented with
the standard error of the mean. A, Significant decrease of prolifer-
ation was noted after 6, 12, and 24 hours rewarming in the
noncooling group, and 60 and 120 seconds cooling without
rewarming compared with the noncooling and nonrewarming
group (*P  .05 compared with 0 hours rewarming and same
cooling condition; †P .05 compared with 0 seconds cooling and
same rewarming time; P  .05 compared with 12 hours rewarm-
ing and same cooling condition). B, No significant changes in
proliferation rate were noted except at 120 seconds of cooling,
followed by 6 and 24 hours of re-warming compared with the same
cooling condition but without re-warming (*P  .05 compared
with 0 hour rewarming and the same cooling condition).6, 12, and 24 hours rewarming (P  .05; Fig 4, B).
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Volume 46, Number 3 Yiu, Cheng, and Sumpio 561For P44/42MAPK phosphorylation, ECs also showed
an increase of phosphorylation with rewarming time (Fig 5,
A), with a significant rise at 120 seconds cooling with 24
hours rewarming by 1.74-fold (P .05), whereas it was the
opposite in SMCs (Fig 5, B). The phosphorylation de-
creased with rewarming time with a significant drop at 0
and 60 seconds cooling with 12 hours rewarming by 0.77-
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Fig 4. Western blot of P70 S6 kinase phosphorylation after su-
percooling and rewarming in (A) endothelial cells (EC) and (B)
smooth muscle cells (SMC). Representative blots of P70 S6 kinase
phosphorylation after 0, 60, and 120 seconds cooling, followed by
0, 6, 12, and 24 hours rewarming. The top immunoblots were
performed with antiphospho-P70 S6 kinase antibody (Thr 421/
Ser 424) and the lower immunoblots were performed with antito-
tal P70 S6 kinase as a control of loading. Densitometeric analysis of
P70 S6 kinase phosphorylation after normalization with loading
control is shown. The fold of activation is indicated on the y axis
and the rewarming hours are indicated on the x-axis. Data are
presented with the standard error of the mean. A, Significant
activation was noted after 60 seconds cooling, followed by 12
hours rewarming (*P  .05 compared with 0 hours rewarming
group under the same cooling condition). B, The P70S6 kinase
activity gradually decreased with significant drop at 0 seconds,
followed by 6, 12, and 24 hours rewarming and 60 seconds
cooling, followed by 12 hours rewarming (*P  .05 compared
with 0 hours rewarming group under the same cooling condition).fold and 0.42-fold, respectively (P  .05).DISCUSSION
Restenosis after balloon angioplasty is a complex pro-
cess. The endothelial denudation is undoubtedly a major
factor, but the subsequent molecular crosstalk between
ECs and SMCs must play a significant role.14 Disruption of
the EC lining can lead to the production of factors regulat-
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Fig 5. Western blot of P44/42 mitogen-activated protein kinase
(MAPK) phosphorylation after supercooling and rewarming in
(A) endothelial cells (EC) and (B) smooth muscle cells (SMC).
Shown are the representative blots of P44/42 MAP kinase after 0,
60, and 120 seconds cooling, followed by 0, 6, 12, and 24 hours
rewarming. The top immunoblots were performed with anti-
phospho-P44/42 MAP kinase antibody (Tyr 202/Tyr 204) and
the low immunoblots were performed with anti-P44/42 MAP
kinase antibody. The densitometeric analysis of P44/42 MAP
kinase phosphorylation after normalization with the loading con-
trol is shown. The y axis represents the fold of activation of P44/42
MAPK and x-axis represents the rewarming hours. A, Increased
EC activation was observed with supercooling and rewarming,
with a significant activation at 120 seconds cooling, followed by 24
hours rewarming (P  .05 compared with 6 hours rewarming
under same cooling condition). B, The activity of P44/42 MAP
kinase phosphorylation decreased gradually with time, with a sig-
nificant drop at 0 seconds cooling, followed by 6 and 12 hours
rewarming and 60 seconds cooling followed by 12 hours rewarm-
ing (*P  .05 compared with 0 hours rewarming and the same
cooling time).ing migration of SMCs and the secretion of extracellular
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prevent restenosis,16 including antiproliferative drugs, in-
travascular radiation, and recently, hypothermia.
Cryoplasty combines the biologic effects of balloon
dilatation with the delivery of cold energy to the vessel wall.
Our preliminary reports indicated that ECs12 and SMCs13
both responded to supercooling and rewarming with an
increase in apoptotic cells. The present study was designed
to directly compare the effects of the two cell types by using
a cryostage that could accommodate a six-well plate. This
enabled us to seed both ECs and SMCs on the same plate,
ensuring that that the experimental conditions were iden-
tical for both cell types. The supplementation of culture
medium with 10% fetal bovine serum is accepted practice
for both ECs and SMCs.17 We intentionally used the same
culture for both to eliminate any confounding factors
due to different culture conditions. In addition, the cryo-
stage was redesigned to ensure that the flow channels were
symmetric under each well to standardize the temperatures
for each well (Fig E1 and Fig E2, online only). The present
study definitively demonstrated that the apoptotic rate of
ECs is significantly less than that of SMCs under the same
conditions, although the apoptotic rate of both cells in-
creased with increasing supercooling and rewarming.
These results provide several potential mechanisms for
the lower restenosis rates reported with cryoplasty. Re-
duced apoptosis of ECs compared with SMCs during con-
ditions of supercooling and rewarming helps preserve the
integrity of the endothelium, an anticoagulant environ-
ment, and amechanical barrier to reduce exposure of SMCs
to any blood-borne proliferative factors, as well as sup-
presses SMC proliferation.18 The relevance of apoptosis of
SMCs in the restenosis process is supported by animal
models. Durand et al19 observed that SMC apoptosis was
significant in the neointimal and media of arteries that had
undergone angioplasty and had subsequent enlargement
remodeling.19 Although it was not proven that SMC apo-
ptosis promoted vessel enlargement, it was clear that the
degree of SMC apoptosis was inversely correlated with
restenosis.
Our results also indicated a greater degree of phosphor-
ylation of AKT in ECs exposed to supercooling and re-
warming. AKT is a downstream regulator of the phospha-
tidylinositol 3-kinase (PI 3-kinase) pathway, and its
activation is characterized by binding of its pleckstrin ho-
mology domain to PI 3-kinase in the cell membrane with
subsequent phosphorylation at Thr 308 and Ser 473.20
AKT activation is critical for cell survival and prevention of
apoptosis in SMCs.21 In a time course comparison of AKT
activation and TUNEL positivity in rat retinas treated with
N-methyl-D-aspartic acid, TUNEL-positive cells could be
detected at 6 and 12 hours after dephosphorylation
of AKT.22 We hypothesize that the higher AKT activation
of ECs compared with SMCs may be part of a cascade of
intracellular events that enable ECs to resist the hypother-
mic insult and is consistent with the lower TUNEL rate in
ECs in our experiments. Future studies characterizing
other signaling proteins that are involved in apoptosiswould be required to further delineate the intracellular
pathway involved in our model.
In this study, we also demonstrated that SMC prolifer-
ation remained low, with a gradual decline under super-
cooling and rewarming conditions. The low cell prolifera-
tion rate correlates with the relatively long SMC cycle time
of 14 to 18 hours.23 Conversely, basal EC proliferation
rates were higher than SMCs, and these rates dropped to
about 10% after supercooling and rewarming conditions.
Although a drop in proliferation rate occurred, ECs still
had a higher rate of BrdU incorporation compared with
SMCs.
Maintenance of proliferation may be important clini-
cally because early re-endothelialization may reduce SMC
migration and proliferation and also potentially reduce the
effects of endothelial dysfunction. Several animal studies
support the key involvement of SMC proliferation in the
restenosis process. In a rabbit carotid artery injury model
using electrical stimulations, maximal intimal SMC prolif-
eration was observed within the first 7 days,24 whereas in a
rabbit femoral artery injury model, SMC proliferation pre-
ceded apoptosis 4 days earlier.19
Caution should always be taken when a direct com-
parison of rates of apoptosis and proliferation by
TUNEL and BrdU is attempted. In contrast to the BrdU
test, which detects proliferating cells that have entered S
phase of the cell cycle 18 hours of the labeling period,
TUNEL assay detects cells that undergo apoptosis for
variable periods of time. The test can also stain cells that
are in the late stage of necrosis, albeit less intensely than
apoptotic cells.25
We also demonstrate that the phosphorylation of P70
S6 kinase and P44/42 MAPK after supercooling and re-
warming was higher overall in ECs compared with SMCs,
which supports our observation that ECs maintained a
higher overall proliferation rate than SMCs. The activation
of P70 S6 kinase is well documented in cell translation
control during the G1 phase.
26 Mitogenic stimulation leads
to phosphorylation of P70 S6 kinase, which in turn leads to
phosphorylation of the S6 protein in the 40S ribosomal
subunit. The phosphorylated S6 protein allows longer en-
gagement of ribosomes in translation.27 MAPK is a well-
known regulator of cell growth and differentiation. MAPK
is activated by a wide variety of different mitogens by the
phosphorylation of threonine and tyrosine residual sites.28
After mitogenic stimulation, the activated MAPK translo-
cates into the nucleus and phosphorylates transcription
factors that regulate the cell cycle. SMC proliferation also
correlates closely to MAPK activation, whereas the dura-
tion of MAPK activation is a function of the mitogenicity.29
MAPK is activated after balloon angioplasty in porcine
carotid and coronary arteries model30 and in a rat carotid
artery model, where the degree of activation depends on
the time of balloon injury.31
Thus, the relatively low intensity of MAPK and P70 S6
kinase phosphorylation correlates with the low prolifera-
tion rate of SMCs in our in vitro model, which may explain
the lower proliferation of SMCs observed in arteries under-
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 3 Yiu, Cheng, and Sumpio 563going cryoplasty in vivo.32 This is further supported by the
fact that continuous activation of MAPK is necessary for
inducing the progression from G0/G1 to S phase. Inhibi-
tion of MAPK activation immediately before the onset of S
phase can lead to the cessation of S phase progression.33
CONCLUSION
We have demonstrated in our in vitro studies that
supercooling and rewarming can exert different effects on
ECs and SMCs. The higher apoptosis and overall low
proliferation rate of SMCs compared with ECsmay provide
an insight into the mechanisms of apoptosis and prolifera-
tion after cryoplasty, which may retard the formation of
restenosis in vivo. Although these effects may be only one
of the mechanisms involved during cryoplasty, our encour-
aging results suggest that the thermal effect of cryoplasty
has an additional benefit compared with conventional an-
gioplasty.
There are, however, several caveats about this study
that still need to be clarified. For instance, we used bovine
vascular cells, and it is not known whether the response to
injury induced by supercooling and rewarming differs in
atherosclerotic lesions in bovine and human. A study using
human vascular SMC from normal coronary arteries and
coronary plaques supports this speculation by showing a
higher rate of apoptosis in SMCs derived from coronary
plaques.34
Likewise, our model does not incorporate other factors
that can affect vascular biology in vivo. These factors in-
clude thermal history and hemodynamic forces that occur
during cryoplasty. Nevertheless, although SMCs are only
one of the factors causing restenosis after angioplasty, we
believe that the data are encouraging and future studies in
the interaction of SMCs and ECs under different thermal
factors would be necessary to fully understand the mecha-
nism of cryoplasty and the possible ways to reduce resteno-
sis after angioplasty in the future.
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livered to each of the six wells of the culture plate.
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Volume 46, Number 3 Yiu, Cheng, and Sumpio 564.e1Fig E1, online only. Diagram shows the design of cry
symmetrically so that the same temperature would be deostage. The flow channels inside the cryostage were created
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September 2007564.e2 Yiu, Cheng, and SumpioFig E2, online only. Cooling curve of medium inside the each well of culture plate. The x axis represents the time on
the cryostage. The y axis represents the temperature changes of medium inside each well. The curve demonstrates the
close similarity of temperature changes in each well.Fig E3, online only. Temperature changes of the PolarCath during cryoplasty. The x axis represents the time of
cryoplasty, and the y axis represents the temperature changes inside the balloon. The temperature dropped to 10°C
at 30 seconds. This is compatible with our cooling curve using 1 mL of medium in culture plate put on the cryostage
set at 21°C.
